Exciting advancements have been made in the field of stem cell therapy with promising data emerging from the first human trial. This progress offers hope for a new approach to Alzheimer’s care, potentially aiding in the healing process of the brain rather than just slowing the disease progression. The Phase 1 study is focused on determining the optimal dose for a future Phase 2 trial. Regeneration Biomedical, the company behind this research, envisions expanding the application of this therapy to other conditions such as multiple sclerosis, Parkinson’s disease, traumatic brain injury, and amyotrophic lateral sclerosis. For further details, interested individuals can contact Regeneration Biomedical at info@regenerationbiomedical.com or visit their website. The potential implications of this research extend beyond Alzheimer’s, opening up possibilities for innovative treatments in various neurological disorders.
Read more about this — here
